[Paraneoplastic neurological autoimmune diseases].
Voltz
R
R
Institut für Klinische Neuroimmunologie, Klinikum Grosshadern, München. rvoltz@nro.med.uni-muenchen.de
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D001323:Autoantibodies / Q000032:analysis; D020274:Autoimmune Diseases of the Nervous System / Q000175:diagnosis* / Q000628:therapy*; D004268:DNA-Binding Proteins / Q000276:immunology; D003937:Diagnosis, Differential; D051959:ELAV Proteins; D006801:Humans; D009363:Neoplasm Proteins / Q000276:immunology; D009419:Nerve Tissue Proteins / Q000276:immunology; D009474:Neurons / Q000276:immunology; D020361:Paraneoplastic Syndromes, Nervous System / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy*; D016601:RNA-Binding Proteins / Q000276:immunology; D013997:Time Factors
D000276:Adjuvants, Immunologic; D001323:Autoantibodies; C095184:CDR2 protein, human; D004268:DNA-Binding Proteins; D051959:ELAV Proteins; D009363:Neoplasm Proteins; D009419:Nerve Tissue Proteins; D016601:RNA-Binding Proteins